Pediatric Cancer

PEDIATRIC CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

Tool May Predict Risk of Subsequent Malignancies in Childhood Cancer Survivors

The tool proved most effective in survivors of solid tumors or central nervous system tumors and in patients not exposed to radiation during treatment of their primary malignancy.
Cisplatin-Induced Hearing Loss Up for Young Children With Cancer

The cumulative incidence of cisplatin-induced hearing loss was 75% in patients age 5 and younger, compared with 48% in older patients.
Children With Cancer Have Greater Risk of Severe COVID-19 Outcomes

About 20% of pediatric cancer patients who developed COVID-19 had severe or critical disease.
‘Excellent’ Outcomes and Room for Improvement in Pediatric Adrenocortical Carcinoma

Patients with stage II or IV disease did not fare as well as patients with stage I or III disease.
Three-Platform Sequencing Provides Detailed Picture of Pediatric Cancers

Testing revealed therapeutically relevant information for some patients.

PEDIATRIC CANCER NEWS

Child with cancer

Genetic Ancestry Impacts Treatment Outcomes in Acute Lymphoblastic Leukemia

September 10, 2021

Pediatric patient

Triplet Deemed New Standard Care for Relapsed or Refractory Rhabdomyosarcoma

August 16, 2021

Melanoma

Real-World Data Show an Overall Decrease in Pediatric Melanoma Diagnoses in the United States

August 16, 2021

Pediatric neuroblastoma

Vorinostat Plus MIBG Proves More Effective Than Other MIBG Regimens in Relapsed or Refractory Neuroblastoma

August 16, 2021

Doctor

Study Reveals Less Toxic Induction Regimen for High-Risk Neuroblastoma

August 6, 2021

Next post in Pediatric Cancer

Child with cancer

Cisplatin-Induced Hearing Loss Up for Young Children With Cancer